Panel Discussion: Unlocking the Potential of RNABased Therapeutics for the Treatment of Rare Kidney Diseases
Time: 11:30 am
day: Conference Day One Track A AM
Details:
- Discovering the renewed hope in siRNA, ASO and other oligonucleotides-based therapeutics for renal disease caused by genetic mutations
- Understanding the reduction in the risk for off-target insertional mutagenesis
- Deliberating the delivery approaches at present and ensuring organ specificity
